Literature DB >> 32712056

Response of dermatomyositis to the antimalarial quinacrine: A retrospective cohort study.

Adarsh Ravishankar1, Daisy Yan1, Christina E Bax1, Josef S Concha1, Rui Feng2, Victoria P Werth3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32712056      PMCID: PMC7854791          DOI: 10.1016/j.jaad.2020.07.081

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

1.  The quinacrine experience in a population of patients with cutaneous lupus erythematosus and dermatomyositis.

Authors:  Lavanya Mittal; Victoria P Werth
Journal:  J Am Acad Dermatol       Date:  2017-08       Impact factor: 11.527

Review 2.  Management of cutaneous dermatomyositis.

Authors:  Christina Lam; Ruth Ann Vleugels
Journal:  Dermatol Ther       Date:  2012 Mar-Apr       Impact factor: 2.851

3.  Antimalarial drug toxicities in patients with cutaneous lupus and dermatomyositis: A retrospective cohort study.

Authors:  Lavanya Mittal; Lingqiao Zhang; Rui Feng; Victoria P Werth
Journal:  J Am Acad Dermatol       Date:  2017-10-06       Impact factor: 11.527

4.  The systemic management of cutaneous dermatomyositis: Results of a stepwise strategy.

Authors:  C O Anyanwu; P B Chansky; R Feng; K Carr; J Okawa; V P Werth
Journal:  Int J Womens Dermatol       Date:  2017-06-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.